249 related articles for article (PubMed ID: 17087311)
21. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
22. Vitamins and minerals 4: overview of folate and the B vitamins.
Thompson J
Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
[TBL] [Abstract][Full Text] [Related]
23. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
24. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
25. Is there really a power shortage in clinical trials testing the "homocysteine hypothesis?".
Hankey GJ; Eikelboom JW; Loh K; Yi Q; Pizzi J; Tang M; Hickling S; Le M; Klijn CJ; Dusitanond P; van Bockxmeer F; Gelavis A; Baker R; Jamrozik K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e147. PubMed ID: 15297291
[No Abstract] [Full Text] [Related]
26. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
Birn H
Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
[TBL] [Abstract][Full Text] [Related]
27. Folate therapy and in-stent restenosis after coronary stenting.
Lange H; Suryapranata H; De Luca G; Börner C; Dille J; Kallmayer K; Pasalary MN; Scherer E; Dambrink JH
N Engl J Med; 2004 Jun; 350(26):2673-81. PubMed ID: 15215483
[TBL] [Abstract][Full Text] [Related]
28. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
[TBL] [Abstract][Full Text] [Related]
29. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
Boxer AL; Kramer JH; Johnston K; Goldman J; Finley R; Miller BL
Neurology; 2005 Apr; 64(8):1431-4. PubMed ID: 15851736
[TBL] [Abstract][Full Text] [Related]
30. [Homocysteine as a coronary risk factor].
Derbeneva SA; Pogozheva AV
Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemia in a cohort of young patients with acute myocardial infarction from Western India: pattern of response to oral folic acid, vitamin B12, B6 therapy.
Ghosh K; Khare A; Shetty S; Kulkarni B
Clin Chim Acta; 2007 Feb; 377(1-2):281-2. PubMed ID: 17069780
[No Abstract] [Full Text] [Related]
32. Vitamins and stroke: the homocysteine hypothesis still in doubt.
Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
[TBL] [Abstract][Full Text] [Related]
33. [Homocysteine and diabetes].
Januła A; Marek B; Kajdaniuk D; Sierek K; Borgiel-Marek H; Kos-Kudła B; Gatnar A; Gnot R; Strzyzewski A; Zeka G; Wyrwas-Bełz U
Wiad Lek; 2005; 58(5-6):319-23. PubMed ID: 16238125
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of homocysteine lowering and cognitive performance.
McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM
N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413
[TBL] [Abstract][Full Text] [Related]
36. [Plasma homocysteine levels in patients with ischemic heart disease].
Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine and essential hypertension.
Rodrigo R; Passalacqua W; Araya J; Orellana M; Rivera G
J Clin Pharmacol; 2003 Dec; 43(12):1299-306. PubMed ID: 14615465
[TBL] [Abstract][Full Text] [Related]
38. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
39. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
Caramia G; Belardinelli R
Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
[TBL] [Abstract][Full Text] [Related]
40. Homocysteine lowering and cardiovascular disease risk: lost in translation.
Marcus J; Sarnak MJ; Menon V
Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
